Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-08-27 Sale | 2020-08-31 4:42 pm | Onconova Therapeutics Inc. | ONTX | Hoffman Michael B Director | 184,368 | $0.2719 | $50,130 | 22,483 (Indirect Direct) | View |
| 2020-01-31 Purchase | 2020-02-05 06:05 am | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 33,333 | $6 | $199,998 | 1,400,175 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-12-20 6:58 pm | N/A N/A | Translational Development Acquisition Corp. | TDAC | TDAC Partners LLC Hoffman Michael B Das Avanindra 10% Owner | 0 | $0 | 4,657,500 (Direct) | View |
Ownership | 2024-12-20 6:54 pm | N/A N/A | Translational Development Acquisition Corp. | TDAC | Hoffman Michael B Chief Executive Officer | 0 | $0 | 4,657,500 (Indirect) | View |
| 2023-11-17 Option Award | 2024-07-03 5:16 pm | N/A 2033-11-17 | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 29,600 | $0 | 29,600 (Direct) | View |
| 2023-11-20 Option Award(A) | 2023-11-22 4:24 pm | N/A N/A | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 163,880 | $6.1 | 1,639,640 (Indirect) | View |
| 2023-11-20 Option Award | 2023-11-21 2:32 pm | N/A N/A | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 164,745 | $6.07 | 1,640,505 (Indirect) | View |
| 2023-04-07 Option Award | 2023-04-11 9:06 pm | N/A N/A | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 59,477 | $12.61 | 1,475,760 (Indirect) | View |
| 2023-01-18 Option Award | 2023-01-20 5:38 pm | N/A 2033-01-18 | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 6,820 | $0 | 6,820 (Direct) | View |
| 2022-01-04 Exercise | 2022-01-05 7:41 pm | 2020-07-01 2030-07-01 | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 37,142 | $0 | 1,425,283 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:41 pm | N/A 2032-01-03 | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 9,000 | $0 | 1,425,283 (Direct) | View |
| 2022-01-04 Tax Withholding | 2022-01-05 7:41 pm | N/A N/A | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 6,748 | $19.78 | 1,425,283 (Direct) | View |
| 2022-01-04 Exercise | 2022-01-05 7:41 pm | N/A N/A | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 7,142 | $0.25 | 1,425,283 (Direct) | View |
| 2022-01-04 Exercise | 2022-01-05 7:41 pm | N/A N/A | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 30,000 | $4.39 | 1,425,283 (Direct) | View |
| 2021-07-07 Option Award | 2021-07-09 6:26 pm | N/A 2031-07-07 | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 4,500 | $0 | 4,500 (Direct) | View |
| 2020-07-09 Option Award | 2020-07-10 5:29 pm | 2021-07-09 2030-07-09 | Onconova Therapeutics Inc. | ONTX | Hoffman Michael B Director | 125,000 | $0 | 125,000 (Direct) | View |
| 2020-07-01 Option Award(A) | 2020-07-06 4:30 pm | 2020-07-01 2030-07-01 | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 30,000 | $0 | 1,415,889 (Direct) | View |
| 2020-01-31 Conversion | 2020-02-05 06:05 am | N/A N/A | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 3,112,012 | $0 | 1,400,175 (Direct) | View |
| 2020-01-31 Conversion | 2020-02-05 06:05 am | N/A N/A | Annovis Bio Inc. | ANVS | Hoffman Michael B Director 10% Owner | 55,884 | $4.8 | 1,400,175 (Direct) | View |
Ownership | 2020-01-29 9:02 pm | N/A N/A | Annovis Bio Inc. | ANVS | Hoffman Michael B Director | 0 | $0 | 1,318,100 (Direct) | View |